FNY Investment Advisers’s Century Therapeutics IPSC Stock Holding History

FNY Investment Advisers’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17K	Hold	10,000	–	–	﹤0.01%	534
2026 Q2	$24K	Buy	+10,000	New	+$22.8K	0.01%	507

Other funds holding IPSC

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

FNY Investment Advisers's IPSC Position: Q3 2026 in Review

FNY Investment Advisers held its Century Therapeutics (IPSC) position steady in Q3 2026 at 10,000 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #534.

FNY Investment Advisers first reported a position in IPSC in Q2 2026 and has held it in 2 quarters since. The position peaked at $24K in Q2 2026. 5 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

FNY Investment Advisers held 10,000 shares of Century Therapeutics worth $17K as of Q3 2026.
FNY Investment Advisers left its Century Therapeutics share count unchanged in Q3 2026.
Century Therapeutics made up ﹤0.01% of FNY Investment Advisers's portfolio in Q3 2026, its #534 holding.
FNY Investment Advisers first reported a position in Century Therapeutics in Q2 2026 and has held it in 2 quarters since.
FNY Investment Advisers's Century Therapeutics position peaked at $24K in Q2 2026.
5 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on FNY Investment Advisers's 13F filing for Q3 2026, filed 16 Oct 2026.